Clinical Trial Update: A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures [Phase 1, Phase 2]

View source ↗

Summary

A dose-ranging pilot study evaluating intracerebroventricular delivery of valproate in temporal seizures completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Valproate (valproate)

Snippet

Sponsor: Cerebral Therapeutics LLC | Conditions: Epilepsy | Phase 1, Phase 2 | Status: COMPLETED